Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 846

1.

Comprehensive evidence and clinical judgment.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2019 Aug;112:v-vi. doi: 10.1016/j.jclinepi.2019.07.004. No abstract available.

PMID:
31376839
2.

Introduction.

March L, Richards B, Gill M, Brooks PM, Shea BJ, Beaton DE, Maxwell LJ, Tunis SR, Grosskleg S, Tugwell P.

J Rheumatol. 2019 Aug;46(8):962-968. doi: 10.3899/jrheum.190105. No abstract available.

PMID:
31371663
3.

Taking an integrated knowledge translation approach in research to develop the CONSORT-Equity 2017 reporting guideline: an observational study.

Jull J, Graham ID, Kristjansson E, Moher D, Petkovic J, Yoganathan M, Tugwell P, Welch VA; AND Members of the CONSORT-Equity 2017 and Boston Equity Symposium.

BMJ Open. 2019 Jul 30;9(7):e026866. doi: 10.1136/bmjopen-2018-026866.

4.

Patient and caregiver priorities for medication adherence in gout, osteoporosis and rheumatoid arthritis: nominal group technique.

Kelly A, Tymms K, de Wit M, Bartlett SJ, Cross M, Dawson T, De Vera M, Evans V, Gill M, Hassett G, Lim I, Manera K, Major G, March L, O'Neill S, Scholte-Voshaar M, Sinnathurai P, Sumpton D, Teixeira-Pinto A, Tugwell P, van den Bemt B, Tong A.

Arthritis Care Res (Hoboken). 2019 Jul 19. doi: 10.1002/acr.24032. [Epub ahead of print]

PMID:
31325214
5.

The scope and consistency of outcomes reported in trials in patients with systemic sclerosis.

Sumpton D, Bigot A, Sautenet B, Craig JC, Hassett G, Thakkar V, Tugwell P, Tong A.

Arthritis Care Res (Hoboken). 2019 Jul 15. doi: 10.1002/acr.24027. [Epub ahead of print]

PMID:
31309737
6.

Letter re: stratification by quality is not recommended in meta-analysis.

Stone J, Gurunathan U, Glass K, Munn Z, Tugwell P, Doi SAR.

J Clin Epidemiol. 2019 Jun 7. pii: S0895-4356(19)30457-3. doi: 10.1016/j.jclinepi.2019.06.004. [Epub ahead of print] No abstract available.

PMID:
31280932
7.

Should the fragility index be routinely reported for systematic reviews?

Tugwell P, Knottnerus A.

J Clin Epidemiol. 2019 Jul;111:v-vi. doi: 10.1016/j.jclinepi.2019.05.008. No abstract available.

PMID:
31178040
8.

Tramadol for osteoarthritis.

Toupin April K, Bisaillon J, Welch V, Maxwell LJ, Jüni P, Rutjes AW, Husni ME, Vincent J, El Hindi T, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2019 May 27;5:CD005522. doi: 10.1002/14651858.CD005522.pub3.

PMID:
31132298
9.

Inadequate comparators produce misleading results - the importance of good comparison practice.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2019 Jun;110:v-vi. doi: 10.1016/j.jclinepi.2019.04.010. No abstract available.

PMID:
31103071
10.

A unified framework for bias assessment in clinical research.

Stone JC, Glass K, Clark J, Munn Z, Tugwell P, Doi SAR.

Int J Evid Based Healthc. 2019 May 10. doi: 10.1097/XEB.0000000000000165. [Epub ahead of print]

PMID:
31094882
11.

Assessing evidence of interventions addressing inequity among migrant populations: a two-stage systematic review.

Yadee J, Bangpan M, Thavorn K, Welch V, Tugwell P, Chaiyakunapruk N.

Int J Equity Health. 2019 May 6;18(1):64. doi: 10.1186/s12939-019-0970-x.

12.

Need for greater transparency in documenting informed consent.

Tugwell P, Knottnerus JA.

J Clin Epidemiol. 2019 May;109:v-vii. doi: 10.1016/j.jclinepi.2019.04.004. No abstract available.

PMID:
31056106
13.

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.

Klokker L, Berthelsen DB, Woodworth T, Andersen KM, Furst DE, Devoe D, Williamson PR, Suarez-Almazor ME, Strand V, Leong AL, Goel N, Boers M, Brooks PM, March L, Sloan VS, Tugwell P, Simon LS, Christensen R.

J Rheumatol. 2019 May 1. pii: jrheum.190196. doi: 10.3899/jrheum.190196. [Epub ahead of print]

PMID:
31043547
14.
15.

WITHDRAWN: Interdental brushing for the prevention and control of periodontal diseases and dental caries in adults.

Poklepovic Pericic T, Worthington HV, Johnson TM, Sambunjak D, Imai P, Clarkson JE, Tugwell P.

Cochrane Database Syst Rev. 2019 Apr 24;4:CD009857. doi: 10.1002/14651858.CD009857.pub3. Review.

PMID:
31017680
16.

WITHDRAWN: Flossing for the management of periodontal diseases and dental caries in adults.

Sambunjak D, Nickerson JW, Poklepovic Pericic T, Johnson TM, Imai P, Tugwell P, Worthington HV.

Cochrane Database Syst Rev. 2019 Apr 23;4:CD008829. doi: 10.1002/14651858.CD008829.pub3. Review.

PMID:
31013348
17.

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

de Wit M, Cooper C, Tugwell P, Bere N, Kirwan J, Conaghan PG, Roberts C, Aujoulat I, Al-Daghri N, Araujo de Carvalho I, Barker M, Bedlington N, Brandi ML, Bruyère O, Burlet N, Halbout P, Hiligsmann M, Jiwa F, Kanis JA, Laslop A, Lawrence W, Pinto D, Prieto Yerro C, Rabenda V, Rizzoli R, Scholte-Voshaar M, Vlaskovska M, Reginster JY.

Aging Clin Exp Res. 2019 Jul;31(7):905-915. doi: 10.1007/s40520-019-01193-8. Epub 2019 Apr 16. Review.

18.

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

Chiarotto A, Kaiser U, Choy E, Christensen R, Conaghan PG, Cowern M, Gill M, de Wit M, Gargon E, Horgan B, Kirkham JJ, Simon LS, Singh JA, Tugwell P, Turk DC, Mease PJ.

J Rheumatol. 2019 Apr 1. pii: jrheum.181099. doi: 10.3899/jrheum.181099. [Epub ahead of print]

PMID:
30936284
19.

Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group.

Verstappen SMM, Lacaille D, Boonen A, Escorpizo R, Hofstetter C, Bosworth A, Leong A, Leggett S, Gignac MAM, Wallman JK, Terwee MM, Berghea F, Agaliotis M, Tugwell P, Beaton D.

J Rheumatol. 2019 Apr 1. pii: jrheum.181201. doi: 10.3899/jrheum.181201. [Epub ahead of print]

PMID:
30936275
20.

Research without good questions is a waste.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2019 Apr;108:vi-viii. doi: 10.1016/j.jclinepi.2019.02.017. No abstract available.

PMID:
30902351
21.

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.

Aydin SZ, Robson JC, Sreih AG, Hill C, Alibaz-Oner F, Mackie S, Beard S, Gul A, Hatemi G, Kermani TA, Mahr A, Meara A, Milman N, Shea B, Tómasson G, Tugwell P, Direskeneli H, Merkel PA.

J Rheumatol. 2019 Mar 15. pii: jrheum.181072. doi: 10.3899/jrheum.181072. [Epub ahead of print]

PMID:
30877212
22.

Human immunodeficiency virus testing and psychosocial outcomes: a scoping review protocol.

Ngobi JB, Pottie K, Leonard L, Tugwell P, Hoffman SJ, Welch V.

JBI Database System Rev Implement Rep. 2019 Aug;17(8):1616-1625. doi: 10.11124/JBISRIR-2017-003864.

PMID:
30864981
23.

Stepped wedge designs are coming of age in clinical epidemiology.

Tugwell P, Knottnerus JA.

J Clin Epidemiol. 2019 Mar;107:vi-viii. doi: 10.1016/j.jclinepi.2019.02.013. No abstract available.

PMID:
30857617
24.

The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future.

Flurey CA, Tugwell PS, Black RJ, Halls S, Page MJ, Robson JC, Sahbudin I, Siddle HJ, Sinnathurai P, Stok KS, Richards B.

J Rheumatol. 2019 Aug;46(8):1047-1052. doi: 10.3899/jrheum.181126. Epub 2019 Mar 1.

PMID:
30824659
25.

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

Smith TO, Mansfield M, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):976-980. doi: 10.3899/jrheum.181066. Epub 2019 Mar 1.

PMID:
30824657
26.

Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis.

Lopez-Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME.

J Rheumatol. 2019 Mar 1. pii: jrheum.181076. doi: 10.3899/jrheum.181076. [Epub ahead of print]

PMID:
30824644
27.

Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion.

Andersen KM, Kelly A, Lyddiatt A, Bingham CO 3rd, Bykerk VP, Batterman A, Westreich J, Jones MK, Cross M, Brooks PM, March L, Shea B, Tugwell P, Simon LS, Christensen R, Bartlett SJ.

J Rheumatol. 2019 Feb 15. pii: jrheum.181185. doi: 10.3899/jrheum.181185. [Epub ahead of print]

PMID:
30770516
28.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
29.

Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.

Humphrey-Murto S, Crew R, Shea B, Bartlett SJ, March L, Tugwell P, Maxwell LJ, Beaton D, Grosskleg S, de Wit M.

J Rheumatol. 2019 Aug;46(8):1041-1046. doi: 10.3899/jrheum.181094. Epub 2019 Feb 15.

PMID:
30770512
30.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
31.

Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.

Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre LM.

Can Pharm J (Ott). 2018 Dec 17;152(1):18-22. doi: 10.1177/1715163518816719. eCollection 2019 Jan-Feb. No abstract available.

32.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.

Toupin-April K, Barton JL, Fraenkel L, Meara A, Li LC, Brooks P, de Wit M, Stacey D, Légaré F, Shea B, Lyddiatt A, Hofstetter C, Christensen R, Scholte Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Karuranga S, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Beaton D, El-Miedany Y, Mittoo S, Bartlett SJ, Singh JA, Tugwell PS.

J Rheumatol. 2019 Feb 1. pii: jrheum.181071. doi: 10.3899/jrheum.181071. [Epub ahead of print]

PMID:
30709963
33.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
34.

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.

Milman N, McConville E, Robson JC, Boonen A, Tugwell P, Wells GA, Chaudhuri D, Dawson J, Tomasson G, Ashdown S, Gebhart D, Lanier G, Peck J, McAlear CA, Kellom KS, Cronholm PF, Merkel PA.

J Rheumatol. 2019 Feb 1. pii: jrheum.181073. doi: 10.3899/jrheum.181073. [Epub ahead of print]

PMID:
30709951
35.

Noblesse oblige: critical issues at the highest level of clinical evidence.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2019 Feb;106:vi-viii. doi: 10.1016/j.jclinepi.2018.12.016. No abstract available.

PMID:
30654870
36.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.

PMID:
30647191
37.

The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.

Smith TO, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Dodd S, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):981-989. doi: 10.3899/jrheum.181194. Epub 2019 Jan 15.

PMID:
30647185
38.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Jan 15. pii: jrheum.181081. doi: 10.3899/jrheum.181081. [Epub ahead of print]

PMID:
30647174
39.

Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group.

Kelly A, Bartlett SJ, de Wit MP, Beaton DE, Dawson T, Evans V, Gill M, Hassett G, March L, Scholte-Voshaar M, Singh JA, Tong A, Tugwell P, Wong P, Tymms K.

J Rheumatol. 2019 Jan 15. pii: jrheum.181078. doi: 10.3899/jrheum.181078. [Epub ahead of print]

PMID:
30647162
40.

Practical Guidance for Involving Stakeholders in Health Research.

Concannon TW, Grant S, Welch V, Petkovic J, Selby J, Crowe S, Synnot A, Greer-Smith R, Mayo-Wilson E, Tambor E, Tugwell P; Multi Stakeholder Engagement (MuSE) Consortium.

J Gen Intern Med. 2019 Mar;34(3):458-463. doi: 10.1007/s11606-018-4738-6. Epub 2018 Dec 18.

PMID:
30565151
41.

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D, Gladman DD.

J Rheumatol. 2019 Aug;46(8):990-995. doi: 10.3899/jrheum.181077. Epub 2018 Dec 15.

PMID:
30554154
42.

Multimorbidity and Comorbidity are now separate MESH headings.

Tugwell P, Knottnerus JA.

J Clin Epidemiol. 2019 Jan;105:vi-viii. doi: 10.1016/j.jclinepi.2018.11.019. No abstract available.

PMID:
30522770
43.

Canada's global health role - Authors' reply.

Nixon SA, Lee K, Bhutta ZA, Blanchard J, Haddad S, Hoffman SJ, Tugwell P.

Lancet. 2018 Dec 1;392(10162):2350-2351. doi: 10.1016/S0140-6736(18)32748-X. No abstract available.

PMID:
30527612
44.

Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines.

Hayawi LM, Graham ID, Tugwell P, Yousef Abdelrazeq S.

PLoS One. 2018 Dec 6;13(12):e0208251. doi: 10.1371/journal.pone.0208251. eCollection 2018. Erratum in: PLoS One. 2019 Apr 24;14(4):e0216196.

45.

Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol.

Sanger N, Shahid H, Dennis BB, Hudson J, Marsh D, Sanger S, Worster A, Teed R, Rieb L, Tugwell P, Hutton B, Shea B, Beaton D, Corace K, Rice D, Maxwell L, Samaan MC, de Souza RJ, Thabane L, Samaan Z.

BMJ Open. 2018 Dec 4;8(12):e025059. doi: 10.1136/bmjopen-2018-025059.

46.

Stratification by quality induced selection bias in a meta-analysis of clinical trials.

Stone J, Gurunathan U, Glass K, Munn Z, Tugwell P, Doi SAR.

J Clin Epidemiol. 2019 Mar;107:51-59. doi: 10.1016/j.jclinepi.2018.11.015. Epub 2018 Nov 17.

PMID:
30458262
47.

Challenges in quantitative analysis need more attention, also in reporting.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2018 Dec;104:vi-viii. doi: 10.1016/j.jclinepi.2018.10.013. No abstract available.

PMID:
30392655
48.

Engaging knowledge users in development of the CONSORT-Equity 2017 reporting guideline: a qualitative study using in-depth interviews.

Jull J, Petticrew M, Kristjansson E, Yoganathan M, Petkovic J, Tugwell P, Welch V; CONSORT-Equity 2017 and Boston Equity Symposium participants.

Res Involv Engagem. 2018 Oct 22;4:34. doi: 10.1186/s40900-018-0118-y. eCollection 2018.

49.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
50.

Potential harms associated with routine collection of patient sociodemographic information: A rapid review.

Petkovic J, Duench SL, Welch V, Rader T, Jennings A, Forster AJ, Tugwell P.

Health Expect. 2019 Feb;22(1):114-129. doi: 10.1111/hex.12837. Epub 2018 Oct 19.

Supplemental Content

Loading ...
Support Center